Rates of Vaccination against COVID-19 in Psychiatric Outpatients.

Publication date: Jul 14, 2024

The aim of this study was to compare the rates of vaccination against COVID-19 infection in psychiatric outpatients and the general population, as well as rates of infected patients. In addition, the level and type of anxiety due to the pandemic were observed in patients with psychotic, anxiety, and depressive disorders. In the present study, 171 patients with pre-existing mental disorders completed the questionnaire about the doses and types of vaccination against COVID-19. During 2021-2023, patients with different mental disorders, aged from 18 to 80, were included. All patients filled in a self-reported questionnaire including general information (age, sex, marriage, education, working status, comorbid conditions) as well as questions about mental health, receiving vaccination, and the course of COVID-19 infection if it was present. All patients gave informed consent for the interview. Patients with pre-existing mental disorders were more likely to be vaccinated against COVID-19 compared with the general population. The Sinopharm vaccine was most frequently applied. In the observed patients, 46. 8% were infected, but just 7% had a medium or serious form of infection and were not vaccinated. In our study, the percentage of vaccinated psychiatric patients was greater than that in the general population, except in psychotic patients, who were mostly limited by fear. Such results can be explained by the high percentage of somatic comorbidities in this population and perhaps insufficient information about the positive effects of vaccination.

Open Access PDF

Concepts Keywords
Covid anxiety
Interview COVID-19
Psychotic depression
Vaccinated mental disorders
somatic health
vaccination

Semantics

Type Source Name
disease VO vaccination
disease MESH COVID-19
disease MESH infection
disease VO population
disease MESH depressive disorders
disease MESH mental disorders
disease VO vaccinated
disease VO vaccine
disease MESH Panic
drug DRUGBANK Coenzyme M
disease VO effective
disease MESH death
disease MESH uncertainty
disease MESH infectious diseases
disease MESH complications
disease MESH delirium
disease MESH encephalitis
disease MESH schizophrenia
disease MESH psychosis
disease VO unvaccinated
disease MESH affective disorders
drug DRUGBANK Methionine
disease MESH marital status
drug DRUGBANK Famciclovir
disease VO document
disease VO frequency
disease MESH comorbidity
disease MESH anxiety disorders
disease VO immunized
drug DRUGBANK Hyaluronic acid
disease VO dose
disease VO vaccine dose
disease MESH hyperlipoproteinemia
disease MESH obesity
disease MESH diabetes mellitus
disease MESH hypercholesterolemia
disease MESH Overweight
disease MESH insomnia
disease MESH unemployment
disease MESH etiology
disease IDO country
drug DRUGBANK Methylergometrine
disease IDO process
drug DRUGBANK Aspartame
disease MESH coronavirus infections
disease MESH influenza
drug DRUGBANK Trestolone
disease MESH bipolar disorder
disease MESH panic disorder
disease VO USA

Original Article

(Visited 2 times, 1 visits today)